These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

719 related articles for article (PubMed ID: 29121177)

  • 21. Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patients.
    Tseng CW; Brook RH; Keeler E; Mangione CM
    JAMA; 2003 Jul; 290(2):222-7. PubMed ID: 12851277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of federal parity on substance use disorder treatment.
    Busch SH; Epstein AJ; Harhay MO; Fiellin DA; Un H; Leader D; Barry CL
    Am J Manag Care; 2014; 20(1):76-82. PubMed ID: 24512166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in spending and service use after a state autism insurance mandate.
    Saloner B; Barry CL
    Autism; 2019 Jan; 23(1):167-174. PubMed ID: 29126371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Out-of-Pocket Spending Not Associated with Oral Oncolytic Survival Benefit.
    Rotenstein LS; Dusetzina SB; Keating NL
    J Manag Care Spec Pharm; 2018 Jun; 24(6):494-502. PubMed ID: 29799324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect on drug utilization and expenditures of a cost-share change from copayment to coinsurance.
    Klepser DG; Huether JR; Handke LJ; Williams CE
    J Manag Care Pharm; 2007; 13(9):765-77. PubMed ID: 18062728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Out-of-Pocket Spending and Premium Contributions After Implementation of the Affordable Care Act.
    Goldman AL; Woolhandler S; Himmelstein DU; Bor DH; McCormick D
    JAMA Intern Med; 2018 Mar; 178(3):347-355. PubMed ID: 29356828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Issues in mental health care benefits: the costs of mental health parity.
    Fronstin P
    EBRI Issue Brief; 1997 Feb; (182):1-14. PubMed ID: 10164993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in Diabetic Prescription Drug Utilization and Costs Among Patients With Diabetes Enrolled in Colorado Marketplace and Medicaid Plans, 2014-2015.
    Khorrami P; Sinha MS; Bhanja A; Allen HL; Kesselheim AS; Sommers BD
    JAMA Netw Open; 2022 Jan; 5(1):e2140371. PubMed ID: 35029667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parity for whom? Exemptions and the extent of state mental health parity legislation.
    Buchmueller TC; Cooper PF; Jacobson M; Zuvekas SH
    Health Aff (Millwood); 2007; 26(4):w483-7. PubMed ID: 17556379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of Newer Antidepressant Medications in U.S. Commercial Health Plans.
    Hodgkin D; Horgan CM; Creedon TB; Merrick EL; Stewart MT
    J Ment Health Policy Econ; 2015 Dec; 18(4):165-73. PubMed ID: 26729008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of out-of-pocket spending caps on financial burden of those with group health insurance.
    Riggs KR; Buttorff C; Alexander GC
    J Gen Intern Med; 2015 May; 30(5):683-8. PubMed ID: 25472507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of incentive-based formularies on prescription-drug utilization and spending.
    Huskamp HA; Deverka PA; Epstein AM; Epstein RS; McGuigan KA; Frank RG
    N Engl J Med; 2003 Dec; 349(23):2224-32. PubMed ID: 14657430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of full mental health and substance abuse parity for children in the Federal Employees Health Benefits Program.
    Azrin ST; Huskamp HA; Azzone V; Goldman HH; Frank RG; Burnam MA; Normand SL; Ridgely MS; Young AS; Barry CL; Busch AB; Moran G
    Pediatrics; 2007 Feb; 119(2):e452-9. PubMed ID: 17272607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimating Premium and Out-of-Pocket Outlays Under All Child Dental Coverage Options in the Federally Facilitated Marketplace.
    Vujicic M; Yarbrough C
    J Pediatr; 2017 Mar; 182():349-355.e1. PubMed ID: 27989408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of the Affordable Care Act's young adult insurance expansion on prescription drug insurance coverage, utilization, and expenditures.
    Look KA; Arora P
    Res Social Adm Pharm; 2016; 12(5):682-98. PubMed ID: 26632980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavioral health benefits for public employees: effect of mental health parity legislation.
    Borzi PC; Rosenbaum S
    Issue Brief George Wash Univ Cent Health Serv Res Policy; 2001 Apr; (13):1-23. PubMed ID: 14982077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prescription drugs: issues of cost, coverage, and quality.
    Copeland C
    EBRI Issue Brief; 1999 Apr; (208):1-21. PubMed ID: 10539445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Out-of-Pocket Spending for Hospitalizations Among Nonelderly Adults.
    Adrion ER; Ryan AM; Seltzer AC; Chen LM; Ayanian JZ; Nallamothu BK
    JAMA Intern Med; 2016 Sep; 176(9):1325-32. PubMed ID: 27367932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Out-of-Pocket Spending on Ultra-Expensive Drugs in Medicare Part D vs Commercial Insurance.
    DiStefano MJ; Kang SY; Parasrampuria S; Anderson GF
    JAMA Health Forum; 2023 May; 4(5):e231090. PubMed ID: 37234016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of Low-Cost Generic Program Use in a Nationally Representative Cohort of Privately Insured Adults.
    Pauly NJ; Brown JD
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1162-70. PubMed ID: 26679965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.